Finepoint Capital LP Reduces Position in Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE)

Finepoint Capital LP cut its position in shares of Cerevel Therapeutics Holdings, Inc. (NASDAQ:CERE – Get Rating) by 3.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm owned 517,287 shares of the biotechnology company’s stock after selling 19,614 shares during the period. […]

Related Keywords

United States ,Canada ,Florida ,American ,Ceon Anthony Coles ,Berenberg Bank ,Cerevel Therapeutics Holdings Inc ,Exchange Commission ,American International Group Inc ,Board Of Administration Florida Retirement System ,Jpmorgan Chase Co ,Wells Fargo Company ,Elequin Securities ,Nasdaq ,Royal Bank ,Finepoint Capital ,Cerevel Therapeutics Holdings ,Get Rating ,Cerevel Therapeutics ,Florida Retirement System ,American International Group ,International Group ,Therapeutics Holdings ,Anthony Coles ,Visit Holdingschannel ,Cerevel Therapeutics Daily ,Nasdaq Cere ,Racere ,Medical ,15677310 ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,